About Ardelyx Inc., (adapted from Ardelyx Inc., prospectus):
They are a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of innovative, non-systemic, small molecule therapeutics that work exclusively in the gastrointestinal, or GI, tract to treat cardio-renal, GI and metabolic diseases.

This description is adapted from Ardelyx prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.